GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (NSE:BROOKS) » Definitions » Cyclically Adjusted PB Ratio

Brooks Laboratories (NSE:BROOKS) Cyclically Adjusted PB Ratio : 2.45 (As of Dec. 16, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories Cyclically Adjusted PB Ratio?

As of today (2024-12-16), Brooks Laboratories's current share price is ₹150.85. Brooks Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 was ₹61.53. Brooks Laboratories's Cyclically Adjusted PB Ratio for today is 2.45.

The historical rank and industry rank for Brooks Laboratories's Cyclically Adjusted PB Ratio or its related term are showing as below:

NSE:BROOKS' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.76   Med: 1.47   Max: 2.48
Current: 2.48

During the past years, Brooks Laboratories's highest Cyclically Adjusted PB Ratio was 2.48. The lowest was 0.76. And the median was 1.47.

NSE:BROOKS's Cyclically Adjusted PB Ratio is ranked worse than
50.84% of 655 companies
in the Drug Manufacturers industry
Industry Median: 2.21 vs NSE:BROOKS: 2.48

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Brooks Laboratories's adjusted book value per share data for the three months ended in Sep. 2024 was ₹22.558. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹61.53 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Brooks Laboratories Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Brooks Laboratories's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories Cyclically Adjusted PB Ratio Chart

Brooks Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.92 1.06 0.94 1.49

Brooks Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.39 - 1.49 - 2.45

Competitive Comparison of Brooks Laboratories's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Brooks Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brooks Laboratories's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brooks Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Brooks Laboratories's Cyclically Adjusted PB Ratio falls into.



Brooks Laboratories Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Brooks Laboratories's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=150.85/61.53
=2.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brooks Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Brooks Laboratories's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book=Book Value per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=22.558/157.8822*157.8822
=22.558

Current CPI (Sep. 2024) = 157.8822.

Brooks Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201412 0.000 96.780 0.000
201503 56.839 97.163 92.359
201506 0.000 99.841 0.000
201509 58.479 101.753 90.737
201512 0.000 102.901 0.000
201603 64.538 102.518 99.391
201606 0.000 105.961 0.000
201609 63.470 105.961 94.570
201612 0.000 105.196 0.000
201703 63.262 105.196 94.946
201706 0.000 107.109 0.000
201709 61.343 109.021 88.835
201712 0.000 109.404 0.000
201803 58.398 109.786 83.981
201806 0.000 111.317 0.000
201809 56.819 115.142 77.910
201812 0.000 115.142 0.000
201903 53.643 118.202 71.651
201906 0.000 120.880 0.000
201909 49.490 123.175 63.435
201912 0.000 126.235 0.000
202003 39.454 124.705 49.951
202006 0.000 127.000 0.000
202009 39.624 130.118 48.079
202012 0.000 130.889 0.000
202103 31.730 131.771 38.018
202106 0.000 134.084 0.000
202109 29.311 135.847 34.065
202112 0.000 138.161 0.000
202203 35.074 138.822 39.890
202206 0.000 142.347 0.000
202209 32.155 144.661 35.094
202212 0.000 145.763 0.000
202303 29.647 146.865 31.871
202306 0.000 150.280 0.000
202309 30.144 151.492 31.416
202312 0.000 152.924 0.000
202403 24.988 153.035 25.780
202406 0.000 155.789 0.000
202409 22.558 157.882 22.558

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Brooks Laboratories  (NSE:BROOKS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Brooks Laboratories Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Brooks Laboratories Business Description

Traded in Other Exchanges
Address
Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. The company operates under one segment: Pharmaceutical products including ingredients and intermediaries. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories Headlines

No Headlines